KLTO - רווח נקי למניה (EPS TTM) ANEW Medical

The current rolling earnings per share level in historical dynamics on the GURU.Markets chart shows that -0.33 is becoming the new value for this metric. Klotho Neurosciences Inc (KLTO) finances rely on preclinical investments. Growth is driven by AI platforms for protein modeling, while the R&D pipeline focuses on s-Klotho therapy against Alzheimer's disease and ALS to combat neurodegeneration.

Investors must identify the real drivers of business resilience through profitability analysis. This metric is calculated as the ratio of total net income over the last four quarters to the total number of shares outstanding. The current annual net income per share objectifies market expectations regarding the issuer's efficiency. For Klotho Neurosciences Inc (KLTO), this indicator reflects the financial return from the implementation of ethical neurobiological technologies and the optimization of energy costs in "green" clouds.